Clinical Trial Update: Evaluation the Effects of Various Treatments on RZL-012-Induced Adverse Events [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating the effects of various treatments on adverse events induced by RZL-012 in submental fat treatment; results completed with posted resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Submental Fat

Drugs mentioned

• RZL-012

Snippet

Sponsor: Raziel Therapeutics Ltd. | Conditions: Submental Fat | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-01-30